To access the full text documents, please follow this link: http://hdl.handle.net/2445/146042
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Berenguer, Diana |
dc.contributor.author | Sosa, Lilian |
dc.contributor.author | Alcover Amengual, Maria Magdalena |
dc.contributor.author | Sessa, Marcella |
dc.contributor.author | Halbaut, Lyda |
dc.contributor.author | Guillen, Carmen |
dc.contributor.author | Fisa Saladrigas, Roser |
dc.contributor.author | Calpena Campmany, Ana Cristina |
dc.contributor.author | Riera Lizandra, Ma. Cristina |
dc.date | 2019-12-04T09:14:15Z |
dc.date | 2019-12-04T09:14:15Z |
dc.date | 2019-11-15 |
dc.date | 2019-12-04T09:14:15Z |
dc.identifier.citation | 1999-4923 |
dc.identifier.citation | 693118 |
dc.identifier.uri | http://hdl.handle.net/2445/146042 |
dc.format | application/pdf |
dc.language.iso | cat |
dc.publisher | MDPI |
dc.relation | Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics11110613 |
dc.relation | Pharmaceutics, 2019 |
dc.relation | https://doi.org/10.3390/pharmaceutics11110613 |
dc.rights | cc-by (c) Berenguer, Diana et al., 2019 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Leishmaniosi |
dc.subject | Leishmania infantum |
dc.subject | Malalties de la pell |
dc.subject | Leishmaniasis |
dc.subject | Leishmania infantum |
dc.subject | Skin diseases |
dc.title | Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis. |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |